InvestorsHub Logo
Followers 45
Posts 5213
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Tuesday, 06/06/2023 10:54:12 AM

Tuesday, June 06, 2023 10:54:12 AM

Post# of 462171
Denali halting their PD trial with Biogunk and their stock goes back up? 4.2 billion dollar MC with 35 million in revenue? Many pieces of pie to go around with partnerships but hard to justify that exorbitant price tag for no results.

We should fly once the first horse gets out of the gate. Our thoroughbreds are primed to run like the wind with RAM, Rett Syndrome.org, Dr. Randi Hagerman, and Dr. Walter Kaufman ushering along our results.

“The first part is going to be the hardest and take the longest but it should expedite the backside.” and “when you see what we did you will understand why we did it this way.”, “tip of the iceberg”……..

Rett Syndrome may be THE straw that breaks the cams back to revenue a d more importantly the start of a plethora of expedited rare disease trials.

God willing.

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News